. Author manuscript; available in PMC: 2016 Jun 24.

Published in final edited form as: J Clin Oncol. 2007 Nov 10;25(32):5051–5057. doi: 10.1200/JCO.2007.11.3324

Table 3.

Cancer Clinical Trials Cooperative Group Open Treatment Trials With PRO Primary or Secondary End Points

	All Open Treatment (CTEP) Trials With PRO End Points
Group	No.^*	%
ACOSOG	2/10	20
ACRIN^†	5/11	45
CALGB	3/76	4
COG	5/101	5
ECOG	8/113	7
EORTC	32/72	26-50
GOG	5/77	7
NCCTG	18/86	21
NCIC	12/25	48
NSABP	5/15	33
RTOG	18/45	40
SWOG	6/133	5

Abbreviations: PRO, patient-related outcome; CTEP, Cancer Therapy Evaluation Program; ACOSOG, American College of Surgeons Oncology Group; ACRIN, American College of Radiology Imaging Network; CALGB, Cancer and Leukemia Group B; COG, Children's Oncology Group; ECOG, Eastern Cooperative Oncology Group; EORTC, European Organisation for Research and Treatment of Cancer; GOG, Gynecologic Oncology Group; NCCTG, North Central Clinical Trials Group; NCIC, National Cancer Institute of Canada; NSABP, National Surgical Adjuvant Breast and Bowel Project; RTOG, Radiation Therapy Oncology Group; SWOG, Southwest Oncology Group.

Numerator is from the cooperative group respondent, and denominator is from National Cancer Institute CTEP Web site (http://ctep.cancer.gov) as of September 2006.

^†

ACRIN open trials refer to imaging trials, not necessarily treatment trials.